Clinical Trial Update: Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated memantine with comprehensive, individualized management of Alzheimer's disease and caregiver training; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Namenda (memantine) (memantine)

Snippet

Sponsor: NYU Langone Health | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2016-07-14